0001209191-23-005746.txt : 20230131
0001209191-23-005746.hdr.sgml : 20230131
20230131171439
ACCESSION NUMBER: 0001209191-23-005746
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230127
FILED AS OF DATE: 20230131
DATE AS OF CHANGE: 20230131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DOYLE THOMAS JAMES
CENTRAL INDEX KEY: 0001910331
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37620
FILM NUMBER: 23573402
MAIL ADDRESS:
STREET 1: C/O KURA ONCOLOGY, INC.
STREET 2: 12730 HIGH BLUFF DRIVE, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kura Oncology, Inc.
CENTRAL INDEX KEY: 0001422143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 611547851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 500-8800
MAIL ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: ZETA ACQUISITION CORP III
DATE OF NAME CHANGE: 20071227
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-27
0
0001422143
Kura Oncology, Inc.
KURA
0001910331
DOYLE THOMAS JAMES
C/O KURA ONCOLOGY, INC.
12730 HIGH BLUFF DRIVE, SUITE 400
SAN DIEGO
CA
92130
0
1
0
0
SVP, Finance & Accounting
Common Stock
2023-01-27
4
S
0
682
13.8898
D
17707
D
Common Stock
2023-01-27
4
S
0
866
13.8902
D
16841
D
Common Stock
500
I
spouse's 401(k)
Sell-to cover for taxes associated with the vesting of RSUs received by the Reporting Person dated 1/26/22.
Includes 1,806 shares acquired on May 17, 2022 and 1,583 shares acquired on November 17, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.
Sell-to cover for taxes associated with the vesting of RSUs received by the Reporting Person dated 2/7/22.
Teresa Bair, Attorney-in-fact for Thomas Doyle
2023-01-31